Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
248 studies found for:    Open Studies | "Hepatitis B"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hepatitis B"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Negative;   Chronic Hepatitis B e Antigen Positive
Intervention: Drug: Peginterferon and Tenofovir
2 Recruiting Observational Study of Persons With Hepatitis B Virus Infection in North America
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
3 Recruiting Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
4 Recruiting Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Condition: Hepatitis B
Intervention: Drug: Entecavir and peginterferon
5 Recruiting "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
Intervention:
6 Recruiting Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate 300mg per day;   Drug: Placebo
7 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir/ & amp;  Emtricitabine;   Drug: Tenofovir
8 Not yet recruiting Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Intervention: Drug: Emtricitabine
9 Recruiting Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis
Conditions: Hepatitis B;   Cholestasis
Interventions: Drug: Ademetionine   2;   Drug: Ademetionine 1;   Drug: Ademetionine 3
10 Recruiting Study for Consolidation Period of Chronic Hepatitis B
Condition: Hepatitis B
Intervention:
11 Unknown  The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma
Conditions: Hepatitis B;   Hepatocellular Carcinoma
Intervention: Procedure: radiofrequency ablation
12 Not yet recruiting Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Intervention: Drug: Emtricitabine
13 Not yet recruiting Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients
Conditions: Hepatitis B, Chronic;   Pregnancy
Intervention: Drug: Emtricitabine
14 Recruiting Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection
Conditions: Hepatitis B, Chronic;   Liver Fibrosis
Intervention: Drug: Treatment with entecavir(Baraclude®)
15 Recruiting HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B
Condition: Hepatitis B
Intervention:
16 Not yet recruiting Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy
Conditions: Lymphoma;   Chronic Hepatitis B
Intervention:
17 Recruiting HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
Condition: Hepatitis B
Intervention:
18 Unknown  Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon alfa-2a;   Drug: Placebo and peginterferon
19 Unknown  Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon (Pegasys) (52 weeks);   Drug: Peginterferon (Pegasys) (96 weeks);   Drug: Peginterferon (Pegasys) (48 weeks)
20 Unknown  Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
Condition: Hepatitis B
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years